VYEPTI.COM: Keyword Density Checker

Total words: 1740 | 2-word phrases: 456 | 3-word phrases: 512 | 4-word phrases: 540

PAGE INFO

Title	Try to keep the title under 60 characters (59 characters) VYEPTI® (eptinezumab-jjmr) IV Migraine Prevention Medicine
Description	Try to keep the meta description between 50 - 160 characters (213 characters) Discover VYEPTI®, the first and only FDA-approved intravenous (IV) infusion treatment for migraine prevention. Find reviews, prescribing information, and more here. See Important Safety Information and full PI.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

ONE WORD PHRASES 232 Words

#	Keyword	Frequency	Density
1	you	29	12.50%
2	to	24	10.34%
3	vyepti	23	9.91%
4	the	22	9.48%
5	or	21	9.05%
6	your	20	8.62%
7	information	20	8.62%
8	of	19	8.19%
9	and	17	7.33%
10	for	15	6.47%

TWO WORD PHRASES 456 Words

#	Keyword	Frequency	Density
1	healthcare provider	11	2.41%
2	you are	10	2.19%
3	side effect	10	2.19%
4	if you	10	2.19%
5	side effects	8	1.75%
6	you have	8	1.75%
7	vyepti® eptinezumabjjmr	8	1.75%
8	for the	6	1.32%
9	tell your	6	1.32%
10	the preventive	6	1.32%
11	effects of	6	1.32%
12	allergic reaction	6	1.32%
13	infusion locator	6	1.32%
14	have a	6	1.32%
15	your healthcare	6	1.32%
16	prescribing information	6	1.32%
17	preventive treatment	6	1.32%
18	patient information	6	1.32%
19	in adults	6	1.32%
20	migraine in	6	1.32%

THREE WORD PHRASES 512 Words

#	Keyword	Frequency	Density
1	if you have	8	1.56%
2	for the preventive	6	1.17%
3	preventive treatment of	6	1.17%
4	you have a	6	1.17%
5	migraine in adults	6	1.17%
6	your healthcare provider	6	1.17%
7	the preventive treatment	6	1.17%
8	side effects of	6	1.17%
9	information información de	4	0.78%
10	you have any	4	0.78%
11	vyepti tell your	4	0.78%
12	tell your healthcare	4	0.78%
13	healthcare provider about	4	0.78%
14	provider about all	4	0.78%
15	effects of vyepti	4	0.78%
16	or plan to	4	0.78%
17	treatment of migraine	4	0.78%
18	of migraine in	4	0.78%
19	directed to a	3	0.59%
20	to a website	3	0.59%
21	facebook iconinstagram icon	3	0.59%
22	vyepti® eptinezumabjjmr logo	3	0.59%
23	emergency medical help	2	0.39%
24	allergic reaction rash	2	0.39%
25	of your face	2	0.39%
26	swelling of your	2	0.39%
27	rash swelling of	2	0.39%
28	reaction rash swelling	2	0.39%
29	have any symptoms	2	0.39%
30	symptoms of an	2	0.39%

FOUR WORD PHRASES 540 Words

#	Keyword	Frequency	Density
1	for the preventive treatment	6	1.11%
2	if you have a	6	1.11%
3	the preventive treatment of	6	1.11%
4	side effects of vyepti	4	0.74%
5	healthcare provider about all	4	0.74%
6	your healthcare provider about	4	0.74%
7	if you have any	4	0.74%
8	tell your healthcare provider	4	0.74%
9	treatment of migraine in	4	0.74%
10	preventive treatment of migraine	4	0.74%
11	of migraine in adults	4	0.74%
12	report negative side effects	2	0.37%
13	intended for us healthcare	2	0.37%
14	negative side effects of	2	0.37%
15	information please see the	2	0.37%
16	please see the prescribing	2	0.37%
17	see the prescribing information	2	0.37%
18	the prescribing information and	2	0.37%
19	and overthecounter medicines vitamins	2	0.37%
20	do not receive vyepti	2	0.37%
21	not receive vyepti if	2	0.37%
22	receive vyepti if you	2	0.37%
23	vyepti if you have	2	0.37%
24	a website intended for	2	0.37%
25	you have a known	2	0.37%
26	have a known allergy	2	0.37%
27	a known allergy to	2	0.37%
28	known allergy to eptinezumabjjmr	2	0.37%
29	prescription and overthecounter medicines	2	0.37%
30	vyepti is a prescription	2	0.37%
31	is a prescription medicine	2	0.37%
32	a prescription medicine used	2	0.37%
33	prescription medicine used for	2	0.37%
34	medicine used for the	2	0.37%
35	used for the preventive	2	0.37%
36	website intended for us	2	0.37%
37	directed to a website	2	0.37%
38	to a website intended	2	0.37%
39	vyepticom and enter a	2	0.37%
40	of vyepti include stuffy	2	0.37%

EXTERNAL LINKS

#	URL	Whois	Check
1	https://www.lundbeck.com/content/dam/lundbeck-com/americas/united-states/products/neurology/vyepti_ppi_us_en.pdf	Whois	lundbeck.com
2	https://www.lundbeck.com/content/dam/lundbeck-com/americas/united-states/products/neurology/vyepti_ppi_us_es.pdf	Whois	lundbeck.com
3	https://www.lundbeck.com/content/dam/lundbeck-com/americas/united-states/products/neurology/vyepti_pi_us_en.pdf	Whois	lundbeck.com
4	https://www.lundbeck.com/content/dam/lundbeck-com/americas/united-states/products/neurology/vyepti_pi_us_es.pdf	Whois	lundbeck.com
5	https://www.vyeptihcp.com	Whois	vyeptihcp.com
6	https://www.lundbeck.com/content/dam/lundbeck-com/americas/united-states/products/neurology/vyepti_ppi_us_en.pdf	Whois	lundbeck.com
7	https://www.lundbeck.com/content/dam/lundbeck-com/americas/united-states/products/neurology/vyepti_ppi_us_es.pdf	Whois	lundbeck.com
8	https://www.lundbeck.com/content/dam/lundbeck-com/americas/united-states/products/neurology/vyepti_pi_us_en.pdf	Whois	lundbeck.com
9	https://www.lundbeck.com/content/dam/lundbeck-com/americas/united-states/products/neurology/vyepti_pi_us_es.pdf	Whois	lundbeck.com
10	https://www.vyeptihcp.com	Whois	vyeptihcp.com
11	https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program	Whois	fda.gov
12	https://www.lundbeck.com/content/dam/lundbeck-com/americas/united-states/products/neurology/vyepti_pi_us_en.pdf	Whois	lundbeck.com
13	https://www.lundbeck.com/content/dam/lundbeck-com/americas/united-states/products/neurology/vyepti_ppi_us_en.pdf	Whois	lundbeck.com
14	https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program	Whois	fda.gov
15	https://www.lundbeck.com/content/dam/lundbeck-com/americas/united-states/products/neurology/vyepti_pi_us_en.pdf	Whois	lundbeck.com
16	https://www.lundbeck.com/content/dam/lundbeck-com/americas/united-states/products/neurology/vyepti_ppi_us_en.pdf	Whois	lundbeck.com
17	https://www.lundbeck.com/us/terms-of-use	Whois	lundbeck.com
18	https://www.lundbeck.com/us/privacy-policy	Whois	lundbeck.com
19	https://www.lundbeck.com/us/contact	Whois	lundbeck.com